nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC22A8—Methotrexate—bone cancer	0.0613	0.589	CbGbCtD
Valaciclovir—SLC22A6—Methotrexate—bone cancer	0.0427	0.41	CbGbCtD
Valaciclovir—Convulsion—Cisplatin—bone cancer	0.00288	0.00321	CcSEcCtD
Valaciclovir—Ataxia—Methotrexate—bone cancer	0.00285	0.00318	CcSEcCtD
Valaciclovir—Renal failure acute—Doxorubicin—bone cancer	0.00284	0.00317	CcSEcCtD
Valaciclovir—Osteoarthritis—Epirubicin—bone cancer	0.00283	0.00316	CcSEcCtD
Valaciclovir—Myalgia—Cisplatin—bone cancer	0.00283	0.00316	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00281	0.00314	CcSEcCtD
Valaciclovir—Liver function test abnormal—Methotrexate—bone cancer	0.0028	0.00312	CcSEcCtD
Valaciclovir—Migraine—Epirubicin—bone cancer	0.00279	0.00311	CcSEcCtD
Valaciclovir—Renal impairment—Doxorubicin—bone cancer	0.00276	0.00308	CcSEcCtD
Valaciclovir—Face oedema—Epirubicin—bone cancer	0.00274	0.00305	CcSEcCtD
Valaciclovir—Anaphylactic shock—Cisplatin—bone cancer	0.00271	0.00303	CcSEcCtD
Valaciclovir—Oedema—Cisplatin—bone cancer	0.00271	0.00303	CcSEcCtD
Valaciclovir—Infection—Cisplatin—bone cancer	0.0027	0.00301	CcSEcCtD
Valaciclovir—Ataxia—Epirubicin—bone cancer	0.00267	0.00298	CcSEcCtD
Valaciclovir—Nervous system disorder—Cisplatin—bone cancer	0.00266	0.00297	CcSEcCtD
Valaciclovir—Thrombocytopenia—Cisplatin—bone cancer	0.00266	0.00297	CcSEcCtD
Valaciclovir—Blood creatinine increased—Epirubicin—bone cancer	0.00266	0.00296	CcSEcCtD
Valaciclovir—Tachycardia—Cisplatin—bone cancer	0.00265	0.00296	CcSEcCtD
Valaciclovir—Dehydration—Epirubicin—bone cancer	0.00264	0.00294	CcSEcCtD
Valaciclovir—Skin disorder—Cisplatin—bone cancer	0.00264	0.00294	CcSEcCtD
Valaciclovir—Osteoarthritis—Doxorubicin—bone cancer	0.00262	0.00293	CcSEcCtD
Valaciclovir—Liver function test abnormal—Epirubicin—bone cancer	0.00262	0.00292	CcSEcCtD
Valaciclovir—Anorexia—Cisplatin—bone cancer	0.00259	0.00289	CcSEcCtD
Valaciclovir—Migraine—Doxorubicin—bone cancer	0.00258	0.00288	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00255	0.00285	CcSEcCtD
Valaciclovir—Nasopharyngitis—Epirubicin—bone cancer	0.00253	0.00283	CcSEcCtD
Valaciclovir—Face oedema—Doxorubicin—bone cancer	0.00253	0.00283	CcSEcCtD
Valaciclovir—Abdominal discomfort—Methotrexate—bone cancer	0.00251	0.0028	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Epirubicin—bone cancer	0.0025	0.00279	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00247	0.00276	CcSEcCtD
Valaciclovir—Ataxia—Doxorubicin—bone cancer	0.00247	0.00275	CcSEcCtD
Valaciclovir—Blood creatinine increased—Doxorubicin—bone cancer	0.00246	0.00274	CcSEcCtD
Valaciclovir—Influenza—Epirubicin—bone cancer	0.00245	0.00273	CcSEcCtD
Valaciclovir—Dehydration—Doxorubicin—bone cancer	0.00244	0.00272	CcSEcCtD
Valaciclovir—Paraesthesia—Cisplatin—bone cancer	0.00244	0.00272	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Methotrexate—bone cancer	0.00243	0.00272	CcSEcCtD
Valaciclovir—Liver function test abnormal—Doxorubicin—bone cancer	0.00242	0.0027	CcSEcCtD
Valaciclovir—Dyspnoea—Cisplatin—bone cancer	0.00242	0.0027	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Methotrexate—bone cancer	0.00239	0.00267	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00236	0.00264	CcSEcCtD
Valaciclovir—Decreased appetite—Cisplatin—bone cancer	0.00236	0.00263	CcSEcCtD
Valaciclovir—Bronchitis—Epirubicin—bone cancer	0.00236	0.00263	CcSEcCtD
Valaciclovir—Nasopharyngitis—Doxorubicin—bone cancer	0.00235	0.00262	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Cisplatin—bone cancer	0.00234	0.00261	CcSEcCtD
Valaciclovir—Depression—Methotrexate—bone cancer	0.00233	0.0026	CcSEcCtD
Valaciclovir—Pain—Cisplatin—bone cancer	0.00232	0.00259	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00231	0.00258	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—bone cancer	0.00229	0.00256	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Epirubicin—bone cancer	0.00228	0.00254	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—bone cancer	0.00228	0.00254	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—bone cancer	0.00227	0.00253	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Epirubicin—bone cancer	0.00224	0.0025	CcSEcCtD
Valaciclovir—Feeling abnormal—Cisplatin—bone cancer	0.00224	0.0025	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—bone cancer	0.00223	0.00248	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—bone cancer	0.00221	0.00246	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—bone cancer	0.00218	0.00243	CcSEcCtD
Valaciclovir—Renal failure—Epirubicin—bone cancer	0.00215	0.0024	CcSEcCtD
Valaciclovir—Body temperature increased—Cisplatin—bone cancer	0.00214	0.00239	CcSEcCtD
Valaciclovir—Stomatitis—Epirubicin—bone cancer	0.00213	0.00238	CcSEcCtD
Valaciclovir—Urinary tract infection—Epirubicin—bone cancer	0.00212	0.00237	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00211	0.00235	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—bone cancer	0.0021	0.00234	CcSEcCtD
Valaciclovir—Haematuria—Epirubicin—bone cancer	0.00208	0.00232	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—bone cancer	0.00208	0.00232	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—bone cancer	0.00207	0.00231	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—bone cancer	0.00207	0.00231	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Epirubicin—bone cancer	0.00207	0.00231	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—bone cancer	0.00205	0.00229	CcSEcCtD
Valaciclovir—Sinusitis—Epirubicin—bone cancer	0.00205	0.00229	CcSEcCtD
Valaciclovir—Hypersensitivity—Cisplatin—bone cancer	0.002	0.00223	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—bone cancer	0.00199	0.00222	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—bone cancer	0.00198	0.00221	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—bone cancer	0.00197	0.0022	CcSEcCtD
Valaciclovir—Rhinitis—Epirubicin—bone cancer	0.00197	0.00219	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—bone cancer	0.00196	0.00219	CcSEcCtD
Valaciclovir—Hepatitis—Epirubicin—bone cancer	0.00196	0.00219	CcSEcCtD
Valaciclovir—Asthenia—Cisplatin—bone cancer	0.00195	0.00217	CcSEcCtD
Valaciclovir—Pharyngitis—Epirubicin—bone cancer	0.00195	0.00217	CcSEcCtD
Valaciclovir—Urinary tract disorder—Epirubicin—bone cancer	0.00194	0.00216	CcSEcCtD
Valaciclovir—Oedema peripheral—Epirubicin—bone cancer	0.00193	0.00216	CcSEcCtD
Valaciclovir—Haematuria—Doxorubicin—bone cancer	0.00193	0.00215	CcSEcCtD
Valaciclovir—Urethral disorder—Epirubicin—bone cancer	0.00192	0.00215	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—bone cancer	0.00191	0.00213	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—bone cancer	0.0019	0.00212	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—bone cancer	0.00189	0.00211	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—bone cancer	0.00189	0.00211	CcSEcCtD
Valaciclovir—Chills—Methotrexate—bone cancer	0.00188	0.0021	CcSEcCtD
Valaciclovir—Diarrhoea—Cisplatin—bone cancer	0.00186	0.00207	CcSEcCtD
Valaciclovir—Erythema multiforme—Epirubicin—bone cancer	0.00185	0.00207	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—bone cancer	0.00185	0.00207	CcSEcCtD
Valaciclovir—Rhinitis—Doxorubicin—bone cancer	0.00182	0.00203	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—bone cancer	0.00181	0.00203	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—bone cancer	0.0018	0.00201	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—bone cancer	0.00179	0.002	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—bone cancer	0.00179	0.002	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—bone cancer	0.00178	0.00199	CcSEcCtD
Valaciclovir—Immune system disorder—Epirubicin—bone cancer	0.00177	0.00198	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—bone cancer	0.00177	0.00197	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—bone cancer	0.00176	0.00197	CcSEcCtD
Valaciclovir—Chills—Epirubicin—bone cancer	0.00176	0.00196	CcSEcCtD
Valaciclovir—Alopecia—Epirubicin—bone cancer	0.00173	0.00193	CcSEcCtD
Valaciclovir—Vomiting—Cisplatin—bone cancer	0.00173	0.00193	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—bone cancer	0.00172	0.00191	CcSEcCtD
Valaciclovir—Rash—Cisplatin—bone cancer	0.00171	0.00191	CcSEcCtD
Valaciclovir—Dermatitis—Cisplatin—bone cancer	0.00171	0.00191	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—bone cancer	0.00169	0.00188	CcSEcCtD
Valaciclovir—Flatulence—Epirubicin—bone cancer	0.00168	0.00188	CcSEcCtD
Valaciclovir—Tension—Epirubicin—bone cancer	0.00168	0.00187	CcSEcCtD
Valaciclovir—Nervousness—Epirubicin—bone cancer	0.00166	0.00185	CcSEcCtD
Valaciclovir—Back pain—Epirubicin—bone cancer	0.00165	0.00184	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—bone cancer	0.00164	0.00183	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—bone cancer	0.00164	0.00183	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—bone cancer	0.00163	0.00182	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—bone cancer	0.00163	0.00182	CcSEcCtD
Valaciclovir—Nausea—Cisplatin—bone cancer	0.00161	0.0018	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—bone cancer	0.0016	0.00179	CcSEcCtD
Valaciclovir—Cough—Methotrexate—bone cancer	0.00159	0.00178	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—bone cancer	0.00158	0.00176	CcSEcCtD
Valaciclovir—Anaemia—Epirubicin—bone cancer	0.00158	0.00176	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—bone cancer	0.00157	0.00175	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—bone cancer	0.00156	0.00174	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—bone cancer	0.00155	0.00173	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—bone cancer	0.00155	0.00173	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—bone cancer	0.00155	0.00173	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—bone cancer	0.00155	0.00173	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00154	0.00172	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—bone cancer	0.00153	0.00171	CcSEcCtD
Valaciclovir—Leukopenia—Epirubicin—bone cancer	0.00153	0.00171	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—bone cancer	0.00153	0.00171	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—bone cancer	0.0015	0.00168	CcSEcCtD
Valaciclovir—Cough—Epirubicin—bone cancer	0.00149	0.00166	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—bone cancer	0.00149	0.00166	CcSEcCtD
Valaciclovir—Convulsion—Epirubicin—bone cancer	0.00148	0.00165	CcSEcCtD
Valaciclovir—Infection—Methotrexate—bone cancer	0.00148	0.00165	CcSEcCtD
Valaciclovir—Hypertension—Epirubicin—bone cancer	0.00147	0.00165	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—bone cancer	0.00146	0.00163	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—bone cancer	0.00146	0.00163	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—bone cancer	0.00146	0.00163	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—bone cancer	0.00145	0.00162	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—bone cancer	0.00145	0.00162	CcSEcCtD
Valaciclovir—Myalgia—Epirubicin—bone cancer	0.00145	0.00162	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—bone cancer	0.00145	0.00162	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—bone cancer	0.00145	0.00161	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00144	0.00161	CcSEcCtD
Valaciclovir—Dry mouth—Epirubicin—bone cancer	0.00142	0.00159	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—bone cancer	0.00142	0.00158	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—bone cancer	0.00141	0.00158	CcSEcCtD
Valaciclovir—Confusional state—Epirubicin—bone cancer	0.0014	0.00157	CcSEcCtD
Valaciclovir—Anaphylactic shock—Epirubicin—bone cancer	0.00139	0.00156	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—bone cancer	0.00139	0.00156	CcSEcCtD
Valaciclovir—Infection—Epirubicin—bone cancer	0.00138	0.00154	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—bone cancer	0.00138	0.00154	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—bone cancer	0.00137	0.00153	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—bone cancer	0.00137	0.00153	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—bone cancer	0.00136	0.00152	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—bone cancer	0.00136	0.00152	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—bone cancer	0.00136	0.00152	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00136	0.00151	CcSEcCtD
Valaciclovir—Skin disorder—Epirubicin—bone cancer	0.00135	0.00151	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—bone cancer	0.00135	0.0015	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—bone cancer	0.00134	0.0015	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—bone cancer	0.00134	0.0015	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—bone cancer	0.00134	0.0015	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—bone cancer	0.00134	0.00149	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00134	0.00149	CcSEcCtD
Valaciclovir—Anorexia—Epirubicin—bone cancer	0.00133	0.00148	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—bone cancer	0.00133	0.00148	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—bone cancer	0.00132	0.00148	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—bone cancer	0.00132	0.00147	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—bone cancer	0.00131	0.00146	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—bone cancer	0.0013	0.00145	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—bone cancer	0.00129	0.00144	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—bone cancer	0.00129	0.00144	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—bone cancer	0.00129	0.00144	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—bone cancer	0.00129	0.00143	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—bone cancer	0.00128	0.00143	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—bone cancer	0.00128	0.00143	CcSEcCtD
Valaciclovir—Pain—Methotrexate—bone cancer	0.00127	0.00142	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00127	0.00142	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—bone cancer	0.00126	0.00141	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—bone cancer	0.00126	0.00141	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—bone cancer	0.00126	0.00141	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—bone cancer	0.00126	0.0014	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—bone cancer	0.00125	0.0014	CcSEcCtD
Valaciclovir—Paraesthesia—Epirubicin—bone cancer	0.00125	0.0014	CcSEcCtD
Valaciclovir—Dyspnoea—Epirubicin—bone cancer	0.00124	0.00139	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—bone cancer	0.00124	0.00138	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—bone cancer	0.00123	0.00137	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—bone cancer	0.00123	0.00137	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—bone cancer	0.00123	0.00137	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—bone cancer	0.00122	0.00136	CcSEcCtD
Valaciclovir—Decreased appetite—Epirubicin—bone cancer	0.00121	0.00135	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Epirubicin—bone cancer	0.0012	0.00134	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—bone cancer	0.0012	0.00134	CcSEcCtD
Valaciclovir—Pain—Epirubicin—bone cancer	0.00119	0.00133	CcSEcCtD
Valaciclovir—Constipation—Epirubicin—bone cancer	0.00119	0.00133	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—bone cancer	0.00118	0.00132	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—bone cancer	0.00118	0.00131	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—bone cancer	0.00118	0.00131	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00117	0.00131	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—bone cancer	0.00117	0.0013	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—bone cancer	0.00116	0.00129	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—bone cancer	0.00115	0.00128	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—bone cancer	0.00115	0.00128	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—bone cancer	0.00115	0.00128	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Epirubicin—bone cancer	0.00114	0.00127	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—bone cancer	0.00113	0.00127	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—bone cancer	0.00112	0.00125	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00111	0.00124	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—bone cancer	0.00111	0.00124	CcSEcCtD
Valaciclovir—Urticaria—Epirubicin—bone cancer	0.00111	0.00124	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—bone cancer	0.0011	0.00123	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—bone cancer	0.0011	0.00123	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—bone cancer	0.0011	0.00123	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—bone cancer	0.0011	0.00123	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—bone cancer	0.0011	0.00122	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—bone cancer	0.00107	0.00119	CcSEcCtD
Valaciclovir—Feeling abnormal—Doxorubicin—bone cancer	0.00106	0.00119	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00105	0.00118	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—bone cancer	0.00105	0.00118	CcSEcCtD
Valaciclovir—Hypersensitivity—Epirubicin—bone cancer	0.00103	0.00115	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—bone cancer	0.00102	0.00114	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—bone cancer	0.00102	0.00114	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—bone cancer	0.00102	0.00114	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—bone cancer	0.00102	0.00114	CcSEcCtD
Valaciclovir—Asthenia—Epirubicin—bone cancer	0.001	0.00112	CcSEcCtD
Valaciclovir—Pruritus—Epirubicin—bone cancer	0.000986	0.0011	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—bone cancer	0.000985	0.0011	CcSEcCtD
Valaciclovir—Diarrhoea—Epirubicin—bone cancer	0.000953	0.00106	CcSEcCtD
Valaciclovir—Hypersensitivity—Doxorubicin—bone cancer	0.00095	0.00106	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—bone cancer	0.000947	0.00106	CcSEcCtD
Valaciclovir—Rash—Methotrexate—bone cancer	0.000939	0.00105	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—bone cancer	0.000938	0.00105	CcSEcCtD
Valaciclovir—Headache—Methotrexate—bone cancer	0.000933	0.00104	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—bone cancer	0.000925	0.00103	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—bone cancer	0.000921	0.00103	CcSEcCtD
Valaciclovir—Pruritus—Doxorubicin—bone cancer	0.000912	0.00102	CcSEcCtD
Valaciclovir—Vomiting—Epirubicin—bone cancer	0.000886	0.000989	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—bone cancer	0.000884	0.000987	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—bone cancer	0.000882	0.000985	CcSEcCtD
Valaciclovir—Rash—Epirubicin—bone cancer	0.000879	0.000981	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—bone cancer	0.000878	0.00098	CcSEcCtD
Valaciclovir—Headache—Epirubicin—bone cancer	0.000873	0.000974	CcSEcCtD
Valaciclovir—Dizziness—Doxorubicin—bone cancer	0.000853	0.000952	CcSEcCtD
Valaciclovir—Nausea—Epirubicin—bone cancer	0.000828	0.000924	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—bone cancer	0.00082	0.000915	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—bone cancer	0.000813	0.000907	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—bone cancer	0.000812	0.000906	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—bone cancer	0.000808	0.000901	CcSEcCtD
Valaciclovir—Nausea—Doxorubicin—bone cancer	0.000766	0.000855	CcSEcCtD
